group b : p less than 0.01 ) reduction in prekallikrein ( 93 and 94 % , respectively ) , inhibition of kallikrein ( 90 and 88 % ) , beta-factor xiia inhibition ( 86 and 85 % ) , and c1 inhibition ( 90 and 91 % ) .
C0033024
prekallikrein
C0022478
kallikrein